Nevro Corp at Jefferies Healthcare Conference Transcript
Welcome to our next session here. So I'm Matt Taylor, the US medical supplies and devices analyst here at Jefferies. And I'm pleased to be joined here by the management team from Nevro, and we're meant to have a 25-minute or so fireside chat. So I'll be asking some questions of the team here.
Just want to introduce everybody first. The CEO and President, Kevin Thornal, who recently joined the company. So it would be great to hear from Kevin. Good to meet you in person, Kevin. And in the middle of the table, there is Rob MacLeod, the CFO; and also Julie Dewey at the end there, who's at both the Chief Communications and IR. And so thanks, everybody, for joining us.
So I wanted to start high level and just talk a little bit about maybe some of the history to give people orientation on the story. Because Nevro has been a real disruptor in the SCS market through history with high frequency. And they're continuing to innovate with data and with some of your new offerings like the HFX platform. So maybe you could expound on that, talk about the philosophy of
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |